J&J expands US OTC recall on more TBA contamination fears
Johnson & Johnson (J&J) has expanded its US OTC drug recall after revealing that many more products than first thought may be contaminated by the wood dye, 2,4,6-tribromoanisole (TBA).
Johnson & Johnson (J&J) has expanded its US OTC drug recall after revealing that many more products than first thought may be contaminated by the wood dye, 2,4,6-tribromoanisole (TBA).
Fujitsu has launched a SaaS-based data management system which it claims can speed up clinical trials, eliminate set up and maintenance costs and allow CROs and sponsors to use the same IT environment.
The EFPIA’s European Vaccine Manufacturers (EVM) group has denied allegations that its members were involved in hyping up the threat of the H1N1 pandemic to boost vaccine sales.
Quintiles Transnational has selected US ePRO solutions provider Invivodata to help it meet growing regulatory pressure to focus on the patient perspectives during trials.
Contract research organisation (CRO) Medpace has acquired Germany-based Medical Consulting Dr Schlichtiger to strengthen its presence in Europe.
The subsidy package used to attract Amylin to Ohio was probably too large and inflated by the biotech’s claim it was considering other locations, according to a report which calls for an end to the “economic war among states”.